Negotiations are still ongoing and the validity of the binding offer has been extended until December 15, Salus said in a filing with the Ljubljana Stock Exchange.
Salus submitted a binding bid for the purchase of the stake in Farmadent on September 24 and set October 19 as a deadline for the validity of its offer but later postponed it to November 3 and then to November 18.
The bid includes an option for the purchase of the remaining 25% stake in Farmadent, or alternatively the company's entire capital.
The potential acquisition of Farmadent is in line with Salus' development strategy, which envisages the expansion of activities in regions where the company is not yet present.